NO318053B1 - Semi-hydroklorid av 8-cyan-1-cyklopropyl-7-(1S,6S-2,8-diazabicyklo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-okso-3-quinolinkarboksylsyre, fremgangsmate for fremstilling derav, anvendelse av forbindelsene samt legemidler inneholdende disse - Google Patents
Semi-hydroklorid av 8-cyan-1-cyklopropyl-7-(1S,6S-2,8-diazabicyklo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-okso-3-quinolinkarboksylsyre, fremgangsmate for fremstilling derav, anvendelse av forbindelsene samt legemidler inneholdende disse Download PDFInfo
- Publication number
- NO318053B1 NO318053B1 NO20012532A NO20012532A NO318053B1 NO 318053 B1 NO318053 B1 NO 318053B1 NO 20012532 A NO20012532 A NO 20012532A NO 20012532 A NO20012532 A NO 20012532A NO 318053 B1 NO318053 B1 NO 318053B1
- Authority
- NO
- Norway
- Prior art keywords
- semi
- ccdc
- hydrochloride
- diluent
- oxo
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims description 9
- -1 nonan-8-yl Chemical group 0.000 title claims description 8
- 238000002360 preparation method Methods 0.000 title claims description 6
- 239000003814 drug Substances 0.000 title claims description 5
- 150000001875 compounds Chemical class 0.000 title description 7
- 229940079593 drug Drugs 0.000 title 1
- IGRCWJPBLWGNPX-UHFFFAOYSA-N 3-(2-chlorophenyl)-n-(4-chlorophenyl)-n,5-dimethyl-1,2-oxazole-4-carboxamide Chemical compound C=1C=C(Cl)C=CC=1N(C)C(=O)C1=C(C)ON=C1C1=CC=CC=C1Cl IGRCWJPBLWGNPX-UHFFFAOYSA-N 0.000 claims description 55
- 239000000203 mixture Substances 0.000 claims description 26
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 19
- 239000003085 diluting agent Substances 0.000 claims description 18
- KSCPLKVBWDOSAI-NKWVEPMBSA-N (4as,7as)-2,3,4,4a,5,6,7,7a-octahydro-1h-pyrrolo[3,4-b]pyridine Chemical compound N1CCC[C@H]2CNC[C@H]21 KSCPLKVBWDOSAI-NKWVEPMBSA-N 0.000 claims description 15
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 15
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 14
- 229910052801 chlorine Inorganic materials 0.000 claims description 14
- 239000000460 chlorine Substances 0.000 claims description 14
- 238000004519 manufacturing process Methods 0.000 claims description 14
- 239000000843 powder Substances 0.000 claims description 11
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 10
- 125000004432 carbon atom Chemical group C* 0.000 claims description 9
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 claims description 9
- HVCNXQOWACZAFN-UHFFFAOYSA-N 4-ethylmorpholine Chemical compound CCN1CCOCC1 HVCNXQOWACZAFN-UHFFFAOYSA-N 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 claims description 5
- LMRKVKPRHROQRR-UHFFFAOYSA-N 4-butylmorpholine Chemical compound CCCCN1CCOCC1 LMRKVKPRHROQRR-UHFFFAOYSA-N 0.000 claims description 4
- NMILGIZTAZXMTM-UHFFFAOYSA-N 4-propylmorpholine Chemical compound CCCN1CCOCC1 NMILGIZTAZXMTM-UHFFFAOYSA-N 0.000 claims description 4
- 238000002844 melting Methods 0.000 claims description 4
- 230000008018 melting Effects 0.000 claims description 4
- YFTHZRPMJXBUME-UHFFFAOYSA-N tripropylamine Chemical compound CCCN(CCC)CCC YFTHZRPMJXBUME-UHFFFAOYSA-N 0.000 claims description 4
- 239000003242 anti bacterial agent Substances 0.000 claims description 3
- 230000011514 reflex Effects 0.000 claims description 3
- 239000000969 carrier Substances 0.000 claims description 2
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- DNIAPMSPPWPWGF-GSVOUGTGSA-N (R)-(-)-Propylene glycol Chemical compound C[C@@H](O)CO DNIAPMSPPWPWGF-GSVOUGTGSA-N 0.000 claims 3
- 229940126601 medicinal product Drugs 0.000 claims 1
- 239000007787 solid Substances 0.000 description 25
- 238000010992 reflux Methods 0.000 description 21
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 14
- 239000002585 base Substances 0.000 description 13
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 12
- BTANRVKWQNVYAZ-UHFFFAOYSA-N butan-2-ol Chemical compound CCC(C)O BTANRVKWQNVYAZ-UHFFFAOYSA-N 0.000 description 12
- 238000000921 elemental analysis Methods 0.000 description 12
- PXTYIFUOEXJZEN-UHFFFAOYSA-N 7-chloro-8-cyano-1-cyclopropyl-6-fluoro-4-oxoquinoline-3-carboxylic acid Chemical compound C12=C(C#N)C(Cl)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 PXTYIFUOEXJZEN-UHFFFAOYSA-N 0.000 description 11
- 239000000243 solution Substances 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- AMQJEAYHLZJPGS-UHFFFAOYSA-N N-Pentanol Chemical compound CCCCCO AMQJEAYHLZJPGS-UHFFFAOYSA-N 0.000 description 8
- ZXEKIIBDNHEJCQ-UHFFFAOYSA-N isobutanol Chemical compound CC(C)CO ZXEKIIBDNHEJCQ-UHFFFAOYSA-N 0.000 description 8
- AVFZOVWCLRSYKC-UHFFFAOYSA-N 1-methylpyrrolidine Chemical compound CN1CCCC1 AVFZOVWCLRSYKC-UHFFFAOYSA-N 0.000 description 6
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 6
- AHVYPIQETPWLSZ-UHFFFAOYSA-N N-methyl-pyrrolidine Natural products CN1CC=CC1 AHVYPIQETPWLSZ-UHFFFAOYSA-N 0.000 description 6
- 238000002329 infrared spectrum Methods 0.000 description 6
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 4
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 238000004455 differential thermal analysis Methods 0.000 description 3
- 235000012907 honey Nutrition 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- 239000002253 acid Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 150000003840 hydrochlorides Chemical class 0.000 description 2
- 238000002076 thermal analysis method Methods 0.000 description 2
- 238000001757 thermogravimetry curve Methods 0.000 description 2
- XOQQVKDBGLYPGH-UHFFFAOYSA-N 2-oxo-1h-quinoline-3-carboxylic acid Chemical compound C1=CC=C2NC(=O)C(C(=O)O)=CC2=C1 XOQQVKDBGLYPGH-UHFFFAOYSA-N 0.000 description 1
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical class CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical group 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 150000007942 carboxylates Chemical class 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- 230000005588 protonation Effects 0.000 description 1
- LOAUVZALPPNFOQ-UHFFFAOYSA-N quinaldic acid Chemical class C1=CC=CC2=NC(C(=O)O)=CC=C21 LOAUVZALPPNFOQ-UHFFFAOYSA-N 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 150000003512 tertiary amines Chemical class 0.000 description 1
- 125000005490 tosylate group Chemical group 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19854357A DE19854357A1 (de) | 1998-11-25 | 1998-11-25 | Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure |
| PCT/EP1999/008778 WO2000031077A1 (de) | 1998-11-25 | 1999-11-15 | Semi-hydrochlorid von 8-cyan-1- cyclopropyl -7-(1s,6s-2, 8-diazabicyclo [4.3.0]nonan -8-yl)-6- fluor-1, 4-dihydro-4- oxo-3- chinolincarbonsäure |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NO20012532D0 NO20012532D0 (no) | 2001-05-23 |
| NO20012532L NO20012532L (no) | 2001-07-02 |
| NO318053B1 true NO318053B1 (no) | 2005-01-24 |
Family
ID=7888961
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20012532A NO318053B1 (no) | 1998-11-25 | 2001-05-23 | Semi-hydroklorid av 8-cyan-1-cyklopropyl-7-(1S,6S-2,8-diazabicyklo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-okso-3-quinolinkarboksylsyre, fremgangsmate for fremstilling derav, anvendelse av forbindelsene samt legemidler inneholdende disse |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6995170B1 (pl) |
| EP (1) | EP1133495B1 (pl) |
| JP (1) | JP2002530408A (pl) |
| KR (1) | KR100740956B1 (pl) |
| CN (1) | CN1176921C (pl) |
| AR (1) | AR023709A1 (pl) |
| AT (1) | ATE225790T1 (pl) |
| AU (1) | AU759769B2 (pl) |
| BR (1) | BR9915684A (pl) |
| CA (1) | CA2351714C (pl) |
| CZ (1) | CZ300058B6 (pl) |
| DE (2) | DE19854357A1 (pl) |
| DK (1) | DK1133495T3 (pl) |
| ES (1) | ES2181488T3 (pl) |
| HK (1) | HK1042704B (pl) |
| HU (1) | HUP0104367A3 (pl) |
| IL (2) | IL142837A0 (pl) |
| NO (1) | NO318053B1 (pl) |
| NZ (1) | NZ511863A (pl) |
| PL (1) | PL196508B1 (pl) |
| PT (1) | PT1133495E (pl) |
| RU (1) | RU2242475C2 (pl) |
| SK (1) | SK285561B6 (pl) |
| TR (1) | TR200101443T2 (pl) |
| TW (1) | TWI234565B (pl) |
| UA (1) | UA67875C2 (pl) |
| WO (1) | WO2000031077A1 (pl) |
| ZA (1) | ZA013317B (pl) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19854357A1 (de) * | 1998-11-25 | 2000-05-31 | Bayer Ag | Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure |
| DE10224086A1 (de) * | 2002-05-31 | 2003-12-11 | Bayer Ag | Pharmazeutische Zubereitungen zur oralen Anwendung enthaltend wirkstoffbeladene Ionentauscherharze sowie strukturviskose Gelbildner als Verdicker |
| DE102004015981A1 (de) * | 2004-04-01 | 2005-10-20 | Bayer Healthcare Ag | Neue kirstalline Form von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure |
| DE102006049520A1 (de) * | 2006-10-20 | 2008-04-24 | Bayer Healthcare Ag | Verfahren zur Herstellung von Pradofloxacin |
| JP7257322B2 (ja) | 2017-02-13 | 2023-04-13 | バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング | プラドフロキサシンを含有する液体組成物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3906365A1 (de) * | 1988-07-15 | 1990-01-18 | Bayer Ag | 7-(1-pyrrolidinyl)-3-chinolon- und -naphthyridoncarbonsaeure-derivate, verfahren sowie substituierte (oxa)diazabicyclooctane und -nonane als zwischenprodukte zu ihrer herstellung, und sie enthaltende antibakterielle mittel und futterzusatzstoffe |
| DE3910663A1 (de) * | 1989-04-03 | 1990-10-04 | Bayer Ag | 5-alkylchinoloncarbonsaeuren |
| DE19546249A1 (de) * | 1995-12-12 | 1997-06-19 | Bayer Ag | Neue Kristallmodifikation des 1-Cyclopropyl-7-([S,S]-2,8-diazabicyclo[4,3,0]non-8-yl)-6-fluor-1,4-dihydro-8-methoxy-4-oxo-3-chinolincarbonsäure Hydrochlorid (CDCH), Verfahren zu dessen Herstellung und diese enthaltende pharmazeutische Zubereitungen |
| JP4338217B2 (ja) * | 1996-02-23 | 2009-10-07 | バイエル・アニマル・ヘルス・ゲゼルシヤフト・ミツト・ベシユレンクテル・ハフツング | 置換可能な８―シアノ―１―シクロプロピル―７―（２，８―ジアザビシクロ―［４．３．０］―ノナン―８―イル）―６―フルオロ―１，４―ジヒドロ―４―オキソ―３―キノリンカルボン酸およびそれらの誘導体 |
| DE19633805A1 (de) * | 1996-02-23 | 1997-08-28 | Bayer Ag | Gegenenenfalls substituierte 8-Cyan-l-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäuren und ihre Derivate |
| DE19854357A1 (de) * | 1998-11-25 | 2000-05-31 | Bayer Ag | Semi-Hydrochlorid von 8-Cyan-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo/4.3.0/ -nonan-8-yl)-6-fluor-1,4-dihydro-4-oxo-3-chinolincarbonsäure |
-
1998
- 1998-11-25 DE DE19854357A patent/DE19854357A1/de not_active Withdrawn
-
1999
- 1999-11-15 WO PCT/EP1999/008778 patent/WO2000031077A1/de active IP Right Grant
- 1999-11-15 DK DK99955995T patent/DK1133495T3/da active
- 1999-11-15 JP JP2000583905A patent/JP2002530408A/ja active Pending
- 1999-11-15 EP EP99955995A patent/EP1133495B1/de not_active Expired - Lifetime
- 1999-11-15 UA UA2001064427A patent/UA67875C2/uk unknown
- 1999-11-15 SK SK684-2001A patent/SK285561B6/sk not_active IP Right Cessation
- 1999-11-15 CN CNB998136743A patent/CN1176921C/zh not_active Expired - Fee Related
- 1999-11-15 PT PT99955995T patent/PT1133495E/pt unknown
- 1999-11-15 HU HU0104367A patent/HUP0104367A3/hu unknown
- 1999-11-15 BR BR9915684-9A patent/BR9915684A/pt not_active Application Discontinuation
- 1999-11-15 IL IL14283799A patent/IL142837A0/xx active IP Right Grant
- 1999-11-15 TR TR2001/01443T patent/TR200101443T2/xx unknown
- 1999-11-15 RU RU2001117528/04A patent/RU2242475C2/ru not_active IP Right Cessation
- 1999-11-15 KR KR1020017005875A patent/KR100740956B1/ko not_active IP Right Cessation
- 1999-11-15 PL PL347799A patent/PL196508B1/pl not_active IP Right Cessation
- 1999-11-15 NZ NZ511863A patent/NZ511863A/en not_active IP Right Cessation
- 1999-11-15 CZ CZ20011753A patent/CZ300058B6/cs not_active IP Right Cessation
- 1999-11-15 ES ES99955995T patent/ES2181488T3/es not_active Expired - Lifetime
- 1999-11-15 TW TW088119809A patent/TWI234565B/zh not_active IP Right Cessation
- 1999-11-15 DE DE59903063T patent/DE59903063D1/de not_active Expired - Lifetime
- 1999-11-15 AT AT99955995T patent/ATE225790T1/de not_active IP Right Cessation
- 1999-11-15 US US09/856,571 patent/US6995170B1/en not_active Expired - Fee Related
- 1999-11-15 AU AU12716/00A patent/AU759769B2/en not_active Ceased
- 1999-11-15 CA CA2351714A patent/CA2351714C/en not_active Expired - Fee Related
- 1999-11-22 AR ARP990105939A patent/AR023709A1/es unknown
-
2001
- 2001-04-24 ZA ZA2001/03317A patent/ZA013317B/en unknown
- 2001-04-27 IL IL142837A patent/IL142837A/en not_active IP Right Cessation
- 2001-05-23 NO NO20012532A patent/NO318053B1/no not_active IP Right Cessation
-
2002
- 2002-06-14 HK HK02104455.8A patent/HK1042704B/zh not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012236841A (ja) | ８−シアノ−１−シクロプロピル−７−（１ｓ，６ｓ−２，８−ジアザビシクロ［４．３．０］ノナン−８−イル）−６−フルオロ−１，４−ジヒドロ−４−オキソ−３−キノリンカルボン酸の結晶変態ｂ | |
| CA1339373C (en) | 6-7-disubstituted 1-cyclopropyl-1,4-dihydro-4-oxo-1,8-naphthyridine-3-c arboxylic acids | |
| NO318053B1 (no) | Semi-hydroklorid av 8-cyan-1-cyklopropyl-7-(1S,6S-2,8-diazabicyklo[4.3.0]nonan-8-yl)-6-fluor-1,4-dihydro-4-okso-3-quinolinkarboksylsyre, fremgangsmate for fremstilling derav, anvendelse av forbindelsene samt legemidler inneholdende disse | |
| US6436955B1 (en) | Crystal modification A of 8-cyano-1-cyclopropyl-7-(is,6s-2,8-diazabicyclo[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid | |
| US6649762B1 (en) | Crystal modification C of 8-cyano-1-cyclopropyl-7-(1S,6S-2,8-diazabicyclo-[4.3.0]nonan-8-yl)-6-fluoro-1,4-dihyro-4-oxo-3-quinoline carboxylic | |
| US6492391B1 (en) | Crystal modification d of 8-cyano-1-cyclopropyl-7-(1s, 6s- 2,8-diazabicyclo-[4.3.0]nonan-8-yl)-6-fluoro-1,4- dihydro-4-oxo-3-quinolinecarboxylic acid | |
| JP2003518016A (ja) | ６−メチル−２−（４−メチル−フェニル）−イミダゾ［１，２−ａ］ピリジン−３−（Ｎ，Ｎ−ジメチル−アセトアミド）の製法及び中間体 | |
| US7834027B2 (en) | Gemifloxacin process and polymorphs | |
| MXPA01005289A (en) | Semi-hydrochloride of 8-cyan-1- cyclopropyl -7-(1s,6s-2 ,8-diazabicyclo [4.3.0]nonan -8-yl)-6- fluoro-1, 4-dihydro -4-oxo-3- quinoline carboxylic acid | |
| MXPA01005229A (en) | Crystal modification b of 8-cyano-1- cyclopropyl -7-(1s,6s-2, 8-diazabicyclo [4.3.0]nonan -8-yl)-6- fluoro-1,4- dihydro-4- oxo-3-quinoline carboxylic acid | |
| MXPA01005230A (en) | Crystal modification a of 8-cyano-1- cyclopropyl -7-(1s,6s-2, 8-diazabicyclo [4.3.0]nonan -8-yl)-6- fluoro-1, 4-dihydro- 4-oxo-3- quinoline carboxylic acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM1K | Lapsed by not paying the annual fees |